celecoxib has been researched along with Contracture in 3 studies
Contracture: Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2 mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the effectiveness of oral administration of non-steroidal anti-inflammatory drug celecoxib (CBX) for the prevention of myogenic and arthrogenic contracture following immobilization in a rat model." | 7.83 | Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. ( Kaneguchi, A; Kito, N; Moriyama, H; Ozawa, J; Tanaka, R, 2016) |
" The purpose of this study was to use a validated rabbit model to assess the effects on surgically-induced knee joint contractures of two combined pharmacological interventions: celecoxib (CXB) loaded on an implanted collagen membrane, and subcutaneously (SQ) injected ketotifen." | 3.96 | Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen. ( Abdel, MP; Berry, CE; Berry, DJ; Bolon, B; Carter, JM; Jay, AG; Limberg, AK; McLaury, AR; Morrey, ME; Salib, CG; Sanchez-Sotelo, J; Tibbo, ME; Turner, TW; van Wijnen, AJ, 2020) |
"The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2 mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the effectiveness of oral administration of non-steroidal anti-inflammatory drug celecoxib (CBX) for the prevention of myogenic and arthrogenic contracture following immobilization in a rat model." | 3.83 | Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. ( Kaneguchi, A; Kito, N; Moriyama, H; Ozawa, J; Tanaka, R, 2016) |
"Arthrofibrosis is a common complication following total knee arthroplasty caused by pathologic fibroblast activation and excessive collagen deposition around a synovial joint leading to debilitating loss of motion." | 1.51 | Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture. ( Abdel, MP; Berry, DJ; Bolon, B; Carter, JM; Jay, AG; Jones, CR; Lewallen, EA; Limberg, AK; Morrey, ME; Paradise, CR; Reina, N; Robin, JX; Salib, CG; Sanchez-Sotelo, J; Tibbo, ME; Trousdale, WH; Turner, TW; van Wijnen, AJ, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Salib, CG | 2 |
Reina, N | 1 |
Trousdale, WH | 1 |
Limberg, AK | 2 |
Tibbo, ME | 2 |
Jay, AG | 2 |
Robin, JX | 1 |
Turner, TW | 2 |
Jones, CR | 1 |
Paradise, CR | 1 |
Lewallen, EA | 1 |
Bolon, B | 2 |
Carter, JM | 2 |
Berry, DJ | 2 |
Morrey, ME | 2 |
Sanchez-Sotelo, J | 2 |
van Wijnen, AJ | 2 |
Abdel, MP | 2 |
McLaury, AR | 1 |
Berry, CE | 1 |
Ozawa, J | 1 |
Kaneguchi, A | 1 |
Tanaka, R | 1 |
Kito, N | 1 |
Moriyama, H | 1 |
3 other studies available for celecoxib and Contracture
Article | Year |
---|---|
Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture.
Topics: Animals; Arthroplasty, Replacement, Knee; Biomechanical Phenomena; Celecoxib; Collagen; Contracture; | 2019 |
Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen.
Topics: Animals; Celecoxib; Contracture; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Delivery | 2020 |
Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees.
Topics: Administration, Oral; Animals; Arthritis; Celecoxib; Contracture; Cyclooxygenase 2; Cyclooxygenase 2 | 2016 |